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and 30.day major adverse cardiac events (MACE) (4.9%). 
Conclusions. ED-initiated 1’PCI for STEMI significantly improved efficiency of cars as 
measured by MDBT, need for subsequent in-hospital intervention. and length of stay. 
Effectiveness measures demonstrating improvement or favorable trends included dis- 
charge medications, survival and MACE. 
1001-208 Multivessel Percutaneous Intervention for ST-Segment 
Elevation Myocardial Infarction: The Mayo Clinic 
Experience 
Ali E. Denktaa James L. Orford, Panayotis Fasseas, Cem Barcin, Ryan J. Lennon, Amir 
Lerman, David R. Holmes, Jr., Mayo Clinic, Rochester, MN 
Introduction: The optimal treatment for patients presenting with ST segment elevation 
myocardial infarction (STEMI) with multiple critical s&noses is not established. In the cur- 
rent era of coronary stenting. with improved procedural outcomes, the simultaneous 
revascularization of multiple critical lesions may be a reasonable therapeutic strategy. 
Mathods: We performed a retrospective analysis of the Mayo Clinic cardiac catheteriza- 
tion laboratory database to compare procedural and clinical outcomes following percuta- 
neous coronary intervention (PCI) between 1995 and 2000 in patients with STEMI who 
underwent multivessel PCI (n=24) with others who underwent only infarct related artery 
(IRA) PCI (n=431). Results: Baseline variables were similar for the multivessel PCI and 
IRA PCI groups: the multivessel PCI group had significantly higher percentages of prior 
by-pass patients (21% vs. 8%, p=O.O4) and of Ilb/llla use (75% vs. 50%, p=O.O2). Proce- 
dural success was similar between the two groups (83% vs. 62%). Logistic regression 
analysis of procedural wccess adjusted for age, gender, and prior bypass surgery failed 
to show that multivessel intervention was a factor (OR 1.22. 95% Cl 0.63, 1.52; p=O.57). 
Mean follow-up of successfully treated patients was 2.2 + 1.5 years in the multivessel 
intervention group and 2.7 * 1.7 years in the single vessel intervention group (p= 0.21). 
The 3.year mortality was not different between the two groups (11.1% vs. 12.9% in the 
single vessel intervention group). Cox analysis of survival free of Ml or target vessel 
revascularizations adjusted for age, gender and the presence of prior by pass surgery 
showed a hazard ratio of 1.51 (95% Cl 0.76, 3.01; ~~0.24) for the multivessel PCI group. 
Conclusion: Multivessel PCI in STEMI was feasible and safe with similar procedural and 
long term clinical outcomes as compared with IRA PCI for patients with multiple critical 
lesions. Prospective, randomized studies evaluating this important clinical observation 
are necessary. 
1001-209 There Is Synergism of AspirinlHeparin With Low 
Frequency Ultrasound for Clot Lysis: Potential for 
Clinical Application in Acute Coronary Syndromes 
Shaul Atar Yoram Neuman, Takashi Miyamoto, Ming Chen, Huai Luo, Sergio Kobal, -I 
Robeti J. Siegel, Cedars-Sinai Medical Center, Los Angeles, CA 
Background: Aspirin (A) andior heparin (H) are commonly used in acute coronary syn- 
dromes and urgent coronary interventions. Low frequency high-intensity ultrasound 
(USD) has been proven to be efficacious and synergistic with various anti-thrombotic and 
fibrinolytic agents for in-vitro and in-viva clot lysis. However, there is currently little data 
on the possible synergism of aspirin with therapeutic USD for thrombus dissolution. 
Methods: Human blood clots from a single donor (n=l60, age 3-6 hours, mean weight 
316+23 mg) were incubated in normal saline and exposed to USD (27 kHz, 30 W, TIMl3, 
Santa Clara, CA) or no USD for 10 and 20 minutes. Clots were treated in solutions con- 
taining aspirin (Lysoprin, Rafa, Israel, lOOmgIL) alone, and in combination with heparin 
(1,000 U/L). The concentrations of A & H were similar to those used as loading doses in 
clinical practice. The absolute percent of clot weight reduction and the relative incremen- 
tal effect of USD exposure (D) were calculated. Results (Table). 
Conclusions: 1) low frequency high-intensity ultrasound significantly increases in-vitro 
clot lysis and is synergistic with aspwin alone or combined with heparin; 2) the highest 
incremental effect of ultrasound on clot lysis with the combination of aspirin and heparin; 
and 3) these findings suggest that transcutaneous low frequency ultrasound in combina- 
tion with ASA and/or heparin has potential in the treatment of acute coronary syndromes. 
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1002-093 Prevalence of Diabetes in Acute Coronary Syndromes: 
The Effects of Gender and Age 
Diane Wall Marwah Abdalla, Amy Arnold, Marcy Adlersberg, Barbara Gulanski, Teresa -I 
Caulin-Glaser, Investigators for The Ethel F. Donaghue Women’s Health Investigator 
Program at Yale, Yale University School of Medicine, New Haven, CT 
Background: Women with Acute Coronary Syndrome (ACS) are at significantly higher 
risk of coronary mortality than men with ACS, a difference that is most apparent in 
younger age groups. It has been hypothesized that diabetes mellitus (DM), a well-known 
risk factor for coronary disease and death, may contribute to the higher mortality rate in 
younger women with coronary artery disease (CAD). Although it has been demonstrated 
that women with CAD have significantly higher rates of DM than men. it is unknown 
whether this gender discrepancy in DM prevalence varies by age. We hypothesize that 
women age 30 - 74 years with ACS would have higher prevalence rates of known DM 
than men, and that this female predilection for diabetes would be most apparent in 
younger age groups. 
Methods: We prospectively reviewed 600 charts of patients age 30 - 74 years who were 
admitted to the Coronary Care Unit or General Cardiac Care Unit at Yale New Haven 
Hospital with suspected ACS, defined as unstable angina (UA) or myocardial infarction 
(Ml). ACS was confirmed in 314 patients whose charts were then examined for history of 
DM to determine whether prevalence varied by gender or age. 
Results: Of the 314 patients aged 30 74 years with confirmed ACS, women had signif- 
icantly higher rates of known DM than men (51% of women versus 27% of men, 
p<O.OOOl for ACS; 48% of women versus 20% of me”, pcO.0002, for Ml only). Further 
analysis revealed that the gender difference in DM prevalence was confined to patients 
below the age of 65. In this group, 53% of women with ACS had DM versus 21% of men 
(p<O.OOl), 48% of women with Ml had DM versus 13% of men (p=O.OOOl), and 60% of 
women with UA had DM versus 35% of men (p=O.O5). Above 65 years, gender differ- 
ences in the prevalence of DM were no longer significant. 
Conclusion: The prevalence of DM is significantly higher in women with CAD than men, 
and this gender difference is specific to patients below age 65 years. Whether the higher 
prevalence of DM in younger women contributes to their higher cardiac-related mortality 
requires further study. 
1002-l 00 Impact of High-Sensitivity C-Reactive Protein on Long- 
Term Mortality of Acute Myocardial Infarction in the 
Reperfusion Era 
Kunihiro Kinio, Hiroshi Sate. Hideyuki Sate, Yozo Ohnishi. Daisaku Nakatani, Hiroya 
Mizuno, Eiji Hishida, Masatsugu HOTI, Osaka University Graduate School of Medicine, 
Suita, Japan 
Background: Because C-reactive protein (CRP) measured shortly after the onset of 
acute myocardial infarction is associated with infarct size. prognostic value of CRP is 
controversial. However, reduction of CRP was accelerated by reperfusion and CRP 
peaked around 3 days after the onset. Therefore, CRP, which was measured at stable 
phase in acute myocardial infarction patients treated predominantly with reperfusion ther- 
apies, may be independent of infarct size and may predict long-term mortality. Purpose: 
To examine whether CRP levels, which were measured at stable phase, are associated 
with infarct size or not and to determine the impact of CRP on long-term mortality of 
acute myocardial infarction in the reperiusion era. Methods: We studied 1309 patients 
with acute myocardial infarction enrolled in Osaka Acute Coronary Insufficiency Study 
between April 1998 and Jun 2001. CRP was measured at 14 days or later (mean. 25 
days after the onset). The patients were followed for a mean 522 days. Results: Reper- 
fusion therapies were performed in 90.0% of patients. Patients in the highest quartile of 
CRP (XI.38 mgldl) were older, had higher prevalence of diabetes mellitus. and had 
higher Killip classes than patients in lower 3 quartiles (~0.38 mg/dl). Multivariate logistic 
regression analysis revealed that CRP was independently associated with age and 
absence of revascularization therapies but was not associated with peak CKZ3OOOlLVL. 
Patients in the highest quartile had higher long-term all-cause mortality and cardiovascu- 
lar mortality rates than patients in lower 3 quartiles (8.9% versus 2.0%, p<O.OOl; 6.4% 
versus 0.8%. p<O.OOl). Multivariate logistic regression analysis revealed that the highest 
quartile was an independent predictor of long-term all-cause mortality (odds ratio, 4.84; 
95% confidence interval, 1.37 to 17.1) and cardiovascular mortality (odds ratio. 10.8; 
